West Pharmaceutical Services, Inc. (WST)
Largest Insider Buys in Sector
WST Stock Price History Chart
WST Stock Performance
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that …
Insider Activity of West Pharmaceutical Services, Inc.
Over the last 12 months, insiders at West Pharmaceutical Services, Inc. have bought $0 and sold $62.43M worth of West Pharmaceutical Services, Inc. stock.
On average, over the past 5 years, insiders at West Pharmaceutical Services, Inc. have bought $0 and sold $34.82M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 108 shares for transaction amount of $11,355 was made by ZENNER PATRICK J () on 2019‑02‑28.
List of Insider Buy and Sell Transactions, West Pharmaceutical Services, Inc.
| 2024-10-29 | Sale | VP & Treasurer | 703 0.0009% | $310.40 | $218,211 | +0.49% | ||
| 2024-08-19 | Sale | VP & Treasurer | 529 0.0007% | $300.00 | $158,700 | +0.31% | ||
| 2024-08-19 | Sale | VP & Treasurer | 1,029 0.0014% | $300.00 | $308,700 | +0.31% | ||
| 2024-08-06 | Sale | President, CEO and Board Chair | 30,732 0.0424% | $304.71 | $9.36M | -1.08% | ||
| 2024-06-12 | Sale | SVP, Chief Technology Officer | 1,800 0.0025% | $330.78 | $595,404 | -10.32% | ||
| 2024-05-10 | Sale | director | 617 0.0009% | $365.92 | $225,773 | -14.55% | ||
| 2024-05-07 | Sale | President, CEO and Board Chair | 66,000 0.0906% | $366.65 | $24.2M | -15.21% | ||
| 2024-03-11 | Sale | VP, Chief Accounting Officer | 815 0.0011% | $358.82 | $292,436 | -9.41% | ||
| 2024-02-28 | Sale | VP & Treasurer | 2,019 0.0028% | $358.62 | $724,061 | -8.31% | ||
| 2024-02-27 | Sale | President, CEO and Board Chair | 64,132 0.0878% | $359.85 | $23.08M | -8.54% | ||
| 2024-02-23 | Sale | SVP, Chief Technology Officer | 7,012 0.0095% | $365.00 | $2.56M | -10.69% | ||
| 2023-12-04 | Sale | VP, Chief Accounting Officer | 1,013 0.0014% | $349.00 | $353,541 | -2.15% | ||
| 2023-12-01 | Sale | VP, Chief Accounting Officer | 1,013 0.0014% | $349.00 | $353,541 | -2.38% | ||
| 2023-10-31 | Sale | VP & Treasurer | 1,190 0.0016% | $322.37 | $383,623 | +9.17% | ||
| 2023-08-30 | Sale | Sr. VP & Chief HR Officer | 2,000 0.0027% | $414.64 | $829,277 | -13.05% | ||
| 2023-08-22 | Sale | Chief Commercial Officer | 3,477 0.0047% | $393.34 | $1.37M | -9.08% | ||
| 2023-08-11 | Sale | VP Strat & Investor Relations | 21,101 0.0285% | $395.12 | $8.34M | -9.26% | ||
| 2023-08-09 | Sale | VP & Treasurer | 1,680 0.0022% | $396.54 | $666,187 | -10.45% | ||
| 2023-08-08 | Sale | President & CEO | 44,000 0.0585% | $394.77 | $17.37M | -10.33% | ||
| 2023-08-08 | Sale | SVP, Chief Technology Officer | 8,160 0.0109% | $397.18 | $3.24M | -10.33% |
Insider Historical Profitability
| Green Eric Mark | President, CEO and Board Chair | 161898 0.2235% | $319.13 | 1 | 7 | +9.65% |
| ZENNER PATRICK J | 66140 0.0913% | $319.13 | 5 | 9 | +14.93% | |
| NEAFSEY JOHN P | director | 40161 0.0555% | $319.13 | 2 | 0 | +12.89% |
| Hunt Jeffrey C | VP Pharma Pckg Systems | 7628 0.0105% | $319.13 | 1 | 2 | +26.41% |
Institutional Investor Ownership
| The Vanguard Group | $3.54B | 12.27 | 8.94M | -0.7% | -$25M | 0.07 | |
| BlackRock | $2.99B | 10.38 | 7.56M | -2.77% | -$85.23M | 0.07 | |
| BNY Mellon | $1.3B | 4.52 | 3.29M | -1.18% | -$15.57M | 0.24 | |
| State Street | $1.27B | 4.42 | 3.22M | -1.62% | -$20.95M | 0.05 | |
| Franklin Templeton Investments | $979.05M | 3.4 | 2.47M | +17.5% | +$145.85M | 0.29 |